Skip To Main Content

Flash e-reader
Choose a chapter:

Go to e-reader chapter

Table Selection
Choose an organ:

Choose a group:

Choose a characteristic:

Requires Adobe Acrobat Reader

Table 7.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Pancreas After Kidney (PAK) Transplants

	No Steroids Used for Maintenance		Steroids Used for Maintenance
	N	%	N	%
Functioning Graft with Immunosuppression Info at Discharge	436	100.0%	715	100.0%
Induction Drugs
Atgam/NRATG/NRATS	6	1.4%	9	1.3%
OKT3	1	0.2%
Thymoglobulin	258	59.2%	403	56.4%
Zenapax	6	1.4%	36	5.0%
Simulect	13	3.0%	47	6.6%
Campath	100	22.9%	74	10.3%
Rituximab			6	0.8%
No Induction Drug Reported	69	15.8%	159	22.2%

Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.